The fundraising comes as the Chinese medical data company is weighing a Hong Kong listing

Health care players should start paying more attention to what kind of medical data they are collecting and how they are protecting it

Deal’s underwriter confirms the listing has been suspended, the first to be nixed since a Chinese regulator announced probes into three freshly listed firms

Company that bills itself as nation’s ‘largest oncology patient-centric continuous care platform’ files for New York listing to raise around $100 million